Let's first agree on the correct terminology. In patients with metastatic colon cancer, maintenance therapy with fluoropyrimidines + bevacizumab after induction with oxaliplatin containing regimen is a standard of care and supported by evidence. On the contrary, I am not aware of any trial that look...